New York, November 04, 2015 -- Moody's Investors Services assigned a B1 rating to U.S. Renal Care, Inc.'s ("U.S. Renal") proposed $1.9 billion senior secured credit facilities, composed of a $150 million revolver and $1.75 billion first lien term loan. In addition, Moody's assigned a Caa1 rating to the company's $265 million second lien term loan. Concurrently, Moody's has confirmed U.S. Renal's B2 Corporate Family Rating and B2-PD Probability of Default Rating. The rating outlook is stable. This rating action concludes the ratings review on U.S. Renal initiated on August 25, 2015. Upon closing of the transaction, all ratings at Dialysis Newco, Inc. ("DSI Renal") will be withdrawn.

Vollständigen Artikel bei Moodys lesen